Non-alcoholic fatty liver disease (NAFLD) affects over 25% of the world’s population, and is projected to be a leading cause of chronic liver disease by 2020. The projected annual economic impact of NAFLD is estimated at $292 billion in the United States annually. First described in 1980, NAFLD is characterized by excessive fat deposition in […]
Author Archives: Health Expert
This study confirms that liver disease is growing rapidly among men, women and young adults. The increase in the rates of liver disease among older adults is attributable to alcohol abuse, hepatitis c, and non-alcoholic fatty liver disease. Surprisingly, younger adults are also experiencing rapid increases in liver cirrhosis, which is attributed to binge drinking […]
Medscape Gastroenterology> Hepatology Highlights Rowen K. Zetterman, MD May 18, 2018 A Problem Increasing in Size Nonalcoholic fatty liver disease (NAFLD) is a condition of hepatic steatosis without significant alcohol intake or another identifiable secondary cause that would result in fat accumulation within hepatocytes. NAFLD is associated with obesity, type 2 diabetes mellitus, and/or hyperlipidemia.[1] Patients with obesity […]
How much do you know about your liver really The liver is the largest glandular organ of the body, weighing about 3 lb (1.36 kg). It is reddish brown in color and is divided into four lobes of unequal size and shape. The liver lies on the right side of the abdominal cavity beneath the […]
Alpha-lipoic acid research Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway Min AK, Kim MK, Seo HY, Kim HS, Jang BK, Hwang JS, Choi HS, Lee KU, Park KG, Lee IK.Biochem Biophys Res Commun. 2010 Mar 12;393(3):536-41. Epub 2010 Feb 12. Accumulating evidence suggests that plasminogen activator inhibitor (PAI)-1 […]
You never see a march about Hepatitis C however, Hepatitis C is a disease of the liver caused by the hepatitis C virus. Hepatitis C is one of the most common (but not the only) diseases that can be contracted through a blood transfusion in the United States. “Hepatitis C already infects three times more people […]
Diagnose With Liver Enzyme Tests Diagnosis is not the end, but the beginning of practice. Martin H. Fischer The most commonly used markers of hepatocyte injury are aspartate aminotransferase (AST), formerly serum glutamic-oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT), formerly serum glutamate-pyruvate transaminase [SGPT]). While ALT is cytosolic, AST has both cytosolic and mitochondrial forms. […]
What is non alcoholic fatty liver disease (NAFLD)? Non alcoholic fatty liver disease (NAFLD) refers to a wide spectrum of liver diseases ranging from the most common, fatty liver (accumulation of fat in the liver, also known as steatosis), to non alcoholic steatohepatitis (NASH, fat in the liver causing liver inflammation), to cirrhosis (irreversible, advanced […]
Roughly 40 Million Americans are at an Increased Risk for Liver Diseases. People Who are Obese, Those With Hepatitis C, People Taking Medications that Damage the Liver, and Those Exposed to High Levels of Environmental Toxins May be More Likely to Get Liver Diseases. Liver Diseases Statistics 1 in 10 Americans are affected by liver […]
Help your Liver Naturally Alpha Lipoic Acid Alpha lipoic acid, also known as thioctic acid, is a disulfide compound that is a co-factor in vital energy-producing reactions in the body. ALA was discovered in 1951, and was first recognized for its effect on liver growth. In the late 1980’s it was recognized for its powerful […]